Axsome Therapeutics Inc (AXSM) — Cash Flow Reinvestment Rate
Latest as of September 2025:
0.11x
Axsome Therapeutics Inc (AXSM) has a Cash Flow Reinvestment Rate of 0.11x as of September 2025, reinvesting $116.00K (capex $58.00K plus investments $-58.00K) from operating cash flow of $1.05 Million. See Axsome Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.11x
(Capex + Investments) / Operating CF
Total Reinvested
$116.00K
Capex + Investments
Operating Cash Flow
$1.05 Million
USD
Capital Expenditures
$58.00K
USD
Annual Cash Flow Reinvestment Rate for Axsome Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Axsome Therapeutics Inc. See AXSM financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow